| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.3 |